(Q37951530)

25 August 2017

title

Glycoconjugate vaccines and immune interactions, and implications for vaccination schedules (English)

1 reference

25 August 2017

1

Ray Borrow

1 reference

25 August 2017

2

Ron Dagan

1 reference

25 August 2017

Fred Zepp

3

1 reference

25 August 2017

Hans Hallander

series ordinal

4

1 reference

25 August 2017

Jan Poolman

series ordinal

5

1 reference

25 August 2017

publication date

1 November 2011

1 reference

Expert Review of Vaccines

25 August 2017

published in

1 reference

25 August 2017

volume

10

1 reference

25 August 2017

issue

11

1 reference

25 August 2017

page(s)

1621-1631

1 reference

Combination vaccines containing DTPa-Hib: impact of IPV and coadministration of CRM197 conjugates

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Glycoconjugate vaccines and immune interference: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Neonatal and infantile immune responses to encapsulated bacteria and conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Immunogenicity of one, two or three doses of a meningococcal C conjugate vaccine conjugated to tetanus toxoid, given as a three-dose primary vaccination course in UK infants at 2, 3 and 4 months of age with acellular pertussis-containing DTP/Hib vac

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

The UK Hib vaccine experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Immunogenicity of a heptavalent conjugate pneumococcal vaccine administered concurrently with a combination diphtheria, tetanus, five-component acellular pertussis, inactivated polio, and Haemophilus influenzae type B vaccine and a meningococcal gro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Difficulties in establishing a serological correlate of protection after immunization with Haemophilus influenzae conjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Haemophilus influenzae b-vaccination: the urgency for timely vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2-7 months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Immunogenicity and reactogenicity of two diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccines administered at 3, 5 and 11-12 months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Immunogenicity of a 2-dose priming and booster vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

Immunogenicity of a Reduced Schedule of Pneumococcal Conjugate Vaccine in Healthy Infants and Correlates of Protection for Serotype 6B in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.142

21 January 2018

Identifiers

DOI

10.1586/ERV.11.142

1 reference

25 August 2017

1 reference